We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VTRS Viatris Inc

0.07 (0.72%)
Dec 08 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 8,616,661
Bid Price 9.80
Ask Price 9.90
News -
Day High 9.92


52 Week Range


Day Low 9.74
Share Name Share Symbol Market Stock Type
Viatris Inc VTRS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.07 0.72% 9.83 17:56:35
Open Price Low Price High Price Close Price Previous Close
9.77 9.74 9.92 9.83 9.76
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
30,056 8,616,661 US$ 9.83 US$ 84,714,530 - 8.74 - 12.3993
Last Trade Type Quantity Price Currency
18:42:26 14 US$ 9.89 USD

Viatris (VTRS) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Viatris Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
11.78B 1.20B - 16.26B 2.08B 1.73 5.67
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Viatris News

Date Time Source News Article
11/24/202317:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/24/202315:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
11/24/202312:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
11/14/202307:00PR Newswire (US)Viatris to Participate in the Jefferies London Healthcare..
11/13/202307:00PR Newswire (US)Viatris and Theravance Biopharma Announce Positive Top-Line..
11/07/202315:39Edgar (US Regulatory)Form 8-K - Current report
11/07/202315:02PR Newswire (US)Viatris Reports Strong Financial and Operational Results for..
11/03/202315:36Edgar (US Regulatory)Form ARS - Annual Report to Security Holders
11/03/202315:33Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
11/03/202315:31Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statements
10/30/202308:00PR Newswire (US)Viatris to Host Webinar: The Power of Partnership to Address..
10/24/202315:32Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No VTRS Message Board. Create One! See More Posts on VTRS Message Board See More Message Board Posts

Historical VTRS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week9.159.929.109.639,122,4800.687.43%
1 Month9.109.928.959.387,986,5520.738.02%
3 Months9.7610.378.749.448,951,3690.070.72%
6 Months9.7011.488.749.928,791,6610.131.34%
1 Year10.9012.39938.7410.209,009,314-1.07-9.82%
3 Years17.5018.868.4212.039,927,785-7.67-43.83%
5 Years16.4618.868.4212.2110,119,183-6.63-40.28%

Viatris Description

We are Viatris. A new kind of global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines advance sustainable operations develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway. Formed in November 2020 we bring together scientific manufacturing and distribution expertise with proven regulatory medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. At Viatris our portfolio comprises more than 1400 approved molecules across a wide range of therapeutic areas spanning both non-communicable and infectious diseases including globally recognized brands complex generic and branded medicines and a growing portfolio of biosimilars.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |